Reviews
Average rating: 5.00/5
Total Reviews: 1
Dr. Curbside
- March 24, 2025
RSVpreF vaccine reduces risk of severe RSV significantly in the approved populations.
Other names: Abrysvo
Categories: Prescription Medication
Description:
The RSVpreF vaccine is a shot that helps protect newborn babies and older adults from getting very sick from RSV (Respiratory Syncytial Virus). It works by training the body to fight off the virus before it causes serious problems. The vaccine is given to pregnant women between weeks 32 and 36 of pregnancy, so their baby is born with protection during their first RSV season. It is also approved for adults aged 60 and older to help prevent lung infections like pneumonia. In studies, the vaccine reduced the risk of severe RSV illness by about 80% in babies and around 85% in older adults.
Treatment For:
AI generated Summary: Based on the single review provided, the RSVpreF vaccine appears to be highly effective in reducing the risk of severe RSV (Respiratory Syncytial Virus) in the approved populations. The reviewer, Dr. Curbside, gave the vaccine a rating of 5 out of 5, suggesting that it is a highly promising treatment for preventing severe RSV infections.
RSVpreF vaccine reduces risk of severe RSV significantly in the approved populations.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
